<DOC>
	<DOCNO>NCT02567136</DOCNO>
	<brief_summary>The purpose study determine able find one biomarkers Amyotrophic Lateral Sclerosis ( ALS ) Primary Lateral Sclerosis ( PLS ) use magnetic resonance imaging ( MRI ) scan different level , 3 tesla ( 3T ) 7 tesla ( 7T ) . A biomarker measurable characteristic use indicator particular disease state . Identifying biomarkers disease lead well understanding disease well improve treatment . This study enroll patient ALS , PLS , healthy control .</brief_summary>
	<brief_title>Imaging Biomarkers ALS</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>21 75 year age inclusive . Willing able give sign informed consent approve Institutional Review Board ( IRB ) . ALS patient : A clinical diagnosis possible , laboratorysupported probable , probable , definite ALS , accord modify El Escorial criterion . Diagnosis neurodegenerative disease ( Parkinson disease , Alzheimer disease , etc ) . Clinically significant history unstable medical illness ( unstable angina , advanced cancer , etc ) last 30 day . Inability undergo MRI scanning , include limited unable remain still MRI scanner 30 minute , claustrophobia , presence paramagnetic substance pacemaker body , weight 300 lb , opinion investigator , strong likelihood subject would able lie flat comfortably 7590 minute . The subject require assistance ambulate OR climb stair , unless opinion investigator , base upon subject 's rate disease progression , subject likely able participate MRI screen 12 month enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>